Clinical proteomics: Cancer diagnostics?

Daniel Wan-Yui Chan, David A. Colantonio

Research output: Contribution to journalArticle

Abstract

It has been just over a decade since the term "proteomics" was coined. Currently, many researchers are taking advantage of proteomic technology to elucidate protein changes between healthy and diseased states. Proteomics is defined as a scientific approach to elucidate all protein species within a cell or tissue. Although the application of proteomic techniques and strategies to the field of medicine is beginning to revolutionize the way biomarker discovery is conducted, the current reality has not always kept pace with previous expectations. The clinical application of proteomics offers much promise for biomarker discovery; however, issues with regards to preanalytical variables, analytical variability, and biological variation must be addressed if further progress is to be gained. This article provides a review of the clinical application of proteomics with the emphasis on current practical issues and challenges facing proteomic research.

Original languageEnglish (US)
Pages (from-to)35-37
Number of pages3
JournalJournal of Clinical Ligand Assay
Volume28
Issue number1
StatePublished - Mar 2005

Fingerprint

Proteomics
Neoplasms
Biomarkers
Medicine
Proteins
Research Personnel
Tissue
Technology
Research

Keywords

  • Biomarker discovery
  • Protein changes
  • Proteomics

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology

Cite this

Clinical proteomics : Cancer diagnostics? / Chan, Daniel Wan-Yui; Colantonio, David A.

In: Journal of Clinical Ligand Assay, Vol. 28, No. 1, 03.2005, p. 35-37.

Research output: Contribution to journalArticle

Chan, DW-Y & Colantonio, DA 2005, 'Clinical proteomics: Cancer diagnostics?', Journal of Clinical Ligand Assay, vol. 28, no. 1, pp. 35-37.
Chan, Daniel Wan-Yui ; Colantonio, David A. / Clinical proteomics : Cancer diagnostics?. In: Journal of Clinical Ligand Assay. 2005 ; Vol. 28, No. 1. pp. 35-37.
@article{e8de28a093904d9e961d44bb62baa608,
title = "Clinical proteomics: Cancer diagnostics?",
abstract = "It has been just over a decade since the term {"}proteomics{"} was coined. Currently, many researchers are taking advantage of proteomic technology to elucidate protein changes between healthy and diseased states. Proteomics is defined as a scientific approach to elucidate all protein species within a cell or tissue. Although the application of proteomic techniques and strategies to the field of medicine is beginning to revolutionize the way biomarker discovery is conducted, the current reality has not always kept pace with previous expectations. The clinical application of proteomics offers much promise for biomarker discovery; however, issues with regards to preanalytical variables, analytical variability, and biological variation must be addressed if further progress is to be gained. This article provides a review of the clinical application of proteomics with the emphasis on current practical issues and challenges facing proteomic research.",
keywords = "Biomarker discovery, Protein changes, Proteomics",
author = "Chan, {Daniel Wan-Yui} and Colantonio, {David A.}",
year = "2005",
month = "3",
language = "English (US)",
volume = "28",
pages = "35--37",
journal = "Journal of Clinical Ligand Assay",
issn = "1081-1672",
publisher = "Clinical Ligand Assay Society Inc.",
number = "1",

}

TY - JOUR

T1 - Clinical proteomics

T2 - Cancer diagnostics?

AU - Chan, Daniel Wan-Yui

AU - Colantonio, David A.

PY - 2005/3

Y1 - 2005/3

N2 - It has been just over a decade since the term "proteomics" was coined. Currently, many researchers are taking advantage of proteomic technology to elucidate protein changes between healthy and diseased states. Proteomics is defined as a scientific approach to elucidate all protein species within a cell or tissue. Although the application of proteomic techniques and strategies to the field of medicine is beginning to revolutionize the way biomarker discovery is conducted, the current reality has not always kept pace with previous expectations. The clinical application of proteomics offers much promise for biomarker discovery; however, issues with regards to preanalytical variables, analytical variability, and biological variation must be addressed if further progress is to be gained. This article provides a review of the clinical application of proteomics with the emphasis on current practical issues and challenges facing proteomic research.

AB - It has been just over a decade since the term "proteomics" was coined. Currently, many researchers are taking advantage of proteomic technology to elucidate protein changes between healthy and diseased states. Proteomics is defined as a scientific approach to elucidate all protein species within a cell or tissue. Although the application of proteomic techniques and strategies to the field of medicine is beginning to revolutionize the way biomarker discovery is conducted, the current reality has not always kept pace with previous expectations. The clinical application of proteomics offers much promise for biomarker discovery; however, issues with regards to preanalytical variables, analytical variability, and biological variation must be addressed if further progress is to be gained. This article provides a review of the clinical application of proteomics with the emphasis on current practical issues and challenges facing proteomic research.

KW - Biomarker discovery

KW - Protein changes

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=24944483153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944483153&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:24944483153

VL - 28

SP - 35

EP - 37

JO - Journal of Clinical Ligand Assay

JF - Journal of Clinical Ligand Assay

SN - 1081-1672

IS - 1

ER -